ConocoPhillips (NYSE:COP) Price Moves 11% Up Last Week Amid Oil Sector Gains
ConocoPhillips saw a 10.9% price increase last week, coinciding with the company's unsuccessful bid to eliminate supermajority voting provisions at its annual stockholder meeting. While the broader market experienced substantial fluctuations due to geopolitical tensions that caused oil prices to surge, ConocoPhillips benefited along with other oil majors. The market's 1.6% upward movement over the same period underscores this positive sentiment within the oil sector. Despite the stock market volatility, influenced by the heightened Middle East conflict, ConocoPhillips managed to gain, reflecting market trends favoring energy stocks amidst climbing oil prices.
We've identified 1 risk with ConocoPhillips and understanding the impact should be part of your investment process.
Find companies with promising cash flow potential yet trading below their fair value.
The recent news surrounding ConocoPhillips's unsuccessful effort to remove supermajority voting provisions could have implications for its future governance and strategic agility. Such changes can influence shareholder sentiment and potentially impact long-term decision-making processes that the company undertakes. Over the past five years, ConocoPhillips shares have delivered a total return of 156.31%, demonstrating robust performance despite shorter-term fluctuations. However, in the past year, ConocoPhillips underperformed the US Oil and Gas industry, which returned 0.8% over the same timeframe.
The company's ambitious plans, such as the Willow and Port Arthur projects, align with its narrative to enhance operational efficiency and shareholder returns but face the challenge of geopolitical tensions and commodity price volatility. These factors could pressure the company's revenue and earnings forecasts, adding complexity to its growth trajectory. Analysts forecast earnings to rise to US$10.5 billion by May 2028, hinging on successful project executions and market stability. The share price movements align with analyst projections, with a 22.22% discount to the consensus price target of US$117.47, indicating potential upside if forecasts are met.
Our valuation report here indicates ConocoPhillips may be undervalued.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NYSE:COP.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Mind Gym Full Year 2025 Earnings: UK£0.082 loss per share (vs UK£0.11 loss in FY 2024)
Revenue: UK£38.6m (down 14% from FY 2024). Net loss: UK£8.19m (loss narrowed by 25% from FY 2024). UK£0.082 loss per share (improved from UK£0.11 loss in FY 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is expected to decline by 2.2% p.a. on average during the next 2 years, while revenues in the Professional Services industry in the United Kingdom are expected to grow by 6.3%. Performance of the British Professional Services industry. The company's share price is broadly unchanged from a week ago. It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Mind Gym (at least 1 which is significant), and understanding these should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
Why IONQ, RGTI and QBTS are Worth the Risk in Quantum Computing
Quantum computing stocks are high-risk, high-reward plays, where the tech still feels futuristic, but the potential upside could be transformative for your portfolio. While giants like NVIDIA (NVDA) and Alphabet (GOOGL) have stakes in the field, pure-play names like IonQ (IONQ), Rigetti Computing (RGTI), and D-Wave Quantum (QBTS) are gaining serious traction. Confident Investing Starts Here: Each is taking a distinct approach in a sector expected to grow significantly over the next decade. With quantum tech reaching what Nvidia's Jensen Huang recently called an 'inflection point,' these companies are riding a powerful wave of both investor excitement and tangible technological progress. IonQ (NYSE:IONQ) | The Trapped-Ion Powerhouse IonQ is shaping up to be the quarterback of the quantum computing world—everyone's watching, and for good reason. Their trapped-ion technology, which uses charged atoms suspended in electromagnetic fields, produces qubits with exceptional coherence times, translating to more stable and reliable calculations. They've already surpassed 100 qubits, and their systems are available across Amazon (AMZN), Microsoft (MSFT), and Google Cloud, making IonQ a top choice for developers building quantum applications. In Q1, IonQ posted $7.6 million in revenue and forecasted full-year revenue between $75–$95 million, nearly doubling last year's figure, while trimming losses to $0.14 per share from $0.19. The buzz lately? Their aggressive M&A strategy. IonQ recently acquired Lightsynq Technologies to accelerate the development of fault-tolerant quantum systems and invested $1 billion in Oxford Ionics to boost R&D, aiming to scale up to 2 million physical qubits by 2030. They've also forged partnerships with heavyweights such as AstraZeneca and Nvidia in quantum-powered drug discovery and secured a key contract under DARPA's Quantum Benchmarking Initiative. Yes, a $10.4 billion market cap is steep given current revenues, but the long-term thesis hinges on IonQ's strategic partnerships, cloud integration, and early mover advantage potentially paying off for investors willing to ride out the volatility. Is IonQ a Buy, Hold, or Sell? Currently, most analysts are bullish on IONQ stock. The stock features a Strong Buy consensus rating based on four Buy and one Hold ratings assigned in the past three months. No analyst rates the stock a sell. IONQ's average stock price target of $43 implies ~11% upside over the next twelve months, despite shares having already rallied about 400% since this time last year. Rigetti Computing (NASDAQ:RGTI) | The Superconducting Maverick Rigetti's story is a bit more turbulent, but still intriguing. Their superconducting gate-based systems are built for speed, executing operations in just 60–80 nanoseconds, far faster than ion-based platforms. That kind of performance is ideal for time-sensitive workloads, such as financial modeling and AI. As a vertically integrated company, Rigetti controls everything from chip design to cloud access, positioning itself for potential large-scale growth. Their 84-qubit Ankaa-3 system debuted in Q1, and they're targeting enterprise clients, including HSBC and Moody's. However, the financial picture is rough. Q1 revenue dropped 52% to $1.47 million, and the company reported a staggering $200.99 million net loss on just $10.79 million in revenue for 2023, highlighting a steep burn rate. Still, Rigetti isn't standing still. They landed a $35 million deal with Quanta Computer, secured a £3.5 million UK consortium lead focused on quantum error correction, and earned DARPA support—solid wins that keep them relevant. Looking ahead, analysts expect revenue to grow to $23 million in 2026 and $38 million in 2027. It's a high-risk play, but if execution improves, Rigetti could be at the start of a long-term turnaround. Is Rigetti Stock a Good Buy? On Wall Street, Rigetti stock carries a Strong Buy consensus rating based on five unanimous Buy ratings. No analyst rates the stock a hold or a sell. RGTI's average stock price target of $15 implies almost 24% upside potential over the next twelve months. D-Wave Quantum (NYSE:QBTS) | The Tempered All-Star D-Wave Quantum is taking a different path—and making no apologies for it. Their quantum annealing technology, designed for optimization tasks like supply chain logistics and drug discovery, is already producing real-world results. Their Advantage2 system, with over 4,400 qubits, recently completed a magnetic simulation in minutes—something a classical supercomputer would take a million years to solve, according to a Science journal paper. In Q1, revenue hit a record $15 million, a sixfold increase year-over-year, with strong momentum expected to continue. The stock has been on a tear, skyrocketing 1,281% over the past year, far outpacing IonQ's 402% and Rigetti's 840%. Their Leap cloud platform is available in 40+ countries and serves 25 Forbes Global 2000 clients, showcasing real commercial traction for quantum. But with a $5.22 billion market cap and a price-to-sales ratio nearing 200x, the valuation is steep and heavily speculative. The key question is whether D-Wave's annealing approach can hold its edge as gate-based systems advance. It's still early days, and the verdict remains uncertain—but for now, D-Wave is proving that practical quantum solutions might not be as far off as once thought. Is D-Wave a Good Stock to Buy? D-Wave is currently covered by six Wall Street analysts, all of whom hold a bullish outlook. The stock carries a Strong Buy consensus rating with all six analysts assigning a Buy rating over the past three months. However, QBTS's average price target of $13 suggests approximately 18% downside potential over the next twelve months. Why Roll the Dice? Quantum computing stocks are far from safe bets—they come with deep losses, sky-high valuations, and intense competition from tech giants like Google and IBM. Still, IonQ's enterprise-ready systems, Rigetti's speed-focused tech, and D-Wave's real-world traction make them standout players in a field with extensive long-term commercialization capacity. While the future of their revenues and profitability remains uncertain, all three deserve a spot on investor watchlists.
Yahoo
2 hours ago
- Yahoo
An Intrinsic Calculation For Staffline Group PLC (LON:STAF) Suggests It's 50% Undervalued
The projected fair value for Staffline Group is UK£0.94 based on 2 Stage Free Cash Flow to Equity Staffline Group's UK£0.47 share price signals that it might be 50% undervalued Peers of Staffline Group are currently trading on average at a 58% premium In this article we are going to estimate the intrinsic value of Staffline Group PLC (LON:STAF) by estimating the company's future cash flows and discounting them to their present value. We will use the Discounted Cash Flow (DCF) model on this occasion. Believe it or not, it's not too difficult to follow, as you'll see from our example! We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (£, Millions) -UK£4.07m UK£5.78m UK£4.87m UK£5.80m UK£6.20m UK£6.41m UK£6.62m UK£6.82m UK£7.01m UK£7.21m Growth Rate Estimate Source Analyst x1 Analyst x2 Analyst x2 Analyst x1 Analyst x1 Est @ 3.47% Est @ 3.19% Est @ 2.99% Est @ 2.86% Est @ 2.76% Present Value (£, Millions) Discounted @ 7.3% -UK£3.8 UK£5.0 UK£3.9 UK£4.4 UK£4.4 UK£4.2 UK£4.1 UK£3.9 UK£3.7 UK£3.6 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = UK£33m We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.5%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.3%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = UK£7.2m× (1 + 2.5%) ÷ (7.3%– 2.5%) = UK£156m Present Value of Terminal Value (PVTV)= TV / (1 + r)10= UK£156m÷ ( 1 + 7.3%)10= UK£77m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is UK£111m. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of UK£0.5, the company appears quite undervalued at a 50% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Staffline Group as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.3%, which is based on a levered beta of 0.922. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for Staffline Group Strength Debt is well covered by cash flow. Weakness Interest payments on debt are not well covered. Opportunity Annual earnings are forecast to grow faster than the British market. Good value based on P/E ratio and estimated fair value. Threat No apparent threats visible for STAF. Whilst important, the DCF calculation is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price sitting below the intrinsic value? For Staffline Group, we've compiled three fundamental items you should explore: Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Staffline Group , and understanding these should be part of your investment process. Future Earnings: How does STAF's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every British stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
